Back to Journals » Journal of Hepatocellular Carcinoma » Volume 9
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Regorafenib Combined with PD-1 Blockade Immunotherapy versus Regorafenib as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Study
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
7,376 | Dovepress* | 6,480+ | 416 | 6,896 | |
PubMed Central* | 896 | 434 | 1,330 | ||
Totals | 7,376 | 850 | 8,226 | ||
*Since 10 March 2022 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed and Google Scholar